1115 related articles for article (PubMed ID: 29669316)
61. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
[TBL] [Abstract][Full Text] [Related]
62. Downregulation of circRNA_100876 Inhibited Progression of NSCLC In Vitro via Targeting miR-636.
Song J; Shi W; Gao Z; Liu X; Wang W
Technol Cancer Res Treat; 2020; 19():1533033820951817. PubMed ID: 33030101
[TBL] [Abstract][Full Text] [Related]
63. MiR-142-5p Suppresses Tumorigenesis by Targeting PIK3CA in Non-Small Cell Lung Cancer.
Wang Z; Liu Z; Fang X; Yang H
Cell Physiol Biochem; 2017; 43(6):2505-2515. PubMed ID: 29131028
[TBL] [Abstract][Full Text] [Related]
64. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
[TBL] [Abstract][Full Text] [Related]
65. MiR-148b suppressed non-small cell lung cancer progression via inhibiting ALCAM through the NF-κB signaling pathway.
Jiang Z; Zhang J; Chen F; Sun Y
Thorac Cancer; 2020 Feb; 11(2):415-425. PubMed ID: 31883226
[TBL] [Abstract][Full Text] [Related]
66. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway.
Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
[TBL] [Abstract][Full Text] [Related]
67. Silencing miR-21 sensitizes non-small cell lung cancer A549 cells to ionizing radiation through inhibition of PI3K/Akt.
Ma Y; Xia H; Liu Y; Li M
Biomed Res Int; 2014; 2014():617868. PubMed ID: 24804226
[TBL] [Abstract][Full Text] [Related]
68. LncRNA SNHG12 regulates the miR-101-3p/CUL4B axis to mediate the proliferation, migration and invasion of non-small cell lung cancer.
Xie FW; Liu JC
Kaohsiung J Med Sci; 2021 Aug; 37(8):664-674. PubMed ID: 34002487
[TBL] [Abstract][Full Text] [Related]
69. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
70. MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.
Wen XP; Ma HL; Zhao LY; Zhang W; Dang CX
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):78-85. PubMed ID: 26025408
[TBL] [Abstract][Full Text] [Related]
71. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
[TBL] [Abstract][Full Text] [Related]
72. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
73. Circular RNA circ‑ACACA regulates proliferation, migration and glycolysis in non‑small‑cell lung carcinoma via miR‑1183 and PI3K/PKB pathway.
Wu W; Xi W; Li H; Yang M; Yao X
Int J Mol Med; 2020 Jun; 45(6):1814-1824. PubMed ID: 32236577
[TBL] [Abstract][Full Text] [Related]
74. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.
Wang Q; Wu H; Wu Q; Zhong S
Drug Dev Res; 2023 Aug; 84(5):907-921. PubMed ID: 37070571
[TBL] [Abstract][Full Text] [Related]
75. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H
Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279
[TBL] [Abstract][Full Text] [Related]
76. The novel miR-873-5p-YWHAE-PI3K/AKT axis is involved in non-small cell lung cancer progression and chemoresistance by mediating autophagy.
Li Z; Liu J; Wang P; Zhang B; He G; Yang L
Funct Integr Genomics; 2024 Feb; 24(2):33. PubMed ID: 38363382
[TBL] [Abstract][Full Text] [Related]
77. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
78. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
[TBL] [Abstract][Full Text] [Related]
79. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
[TBL] [Abstract][Full Text] [Related]
80. Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p/purine rich element binding protein B-mediated MAPK and PI3K/Akt signaling pathways.
Pan J; Cai X; Zheng X; Zhu X; Feng J; Wang X
Tissue Cell; 2022 Apr; 75():101740. PubMed ID: 35101688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]